MedTrace Logo

Vincristine PK and PD in the AYA Population Compared to Younger Children

NCT02360930 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-06-22

No results posted yet for this study

Summary

The trial is to determine if a difference exists in the way that adolescents and young adults metabolize the chemotherapy agent vincristine compared to younger children.

Conditions

  • Leukemia, Acute Lymphoblastic
  • Leukemia

Sponsors & Collaborators

Principal Investigators

  • Lakshmi Damerla · Children's Hospital Los Angeles

Eligibility

Min Age
1 Year
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02360930 on ClinicalTrials.gov